Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection

Published:2020-04 Issue:2 Volume:31 Page:107494
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Cham Lamin B.,Torrez Dulgeroff Laughing Bear,Tal Michal Caspi,Adomati Tom,Li Fanghui,Bhat Hilal,Huang Anfei,Lang Philipp A.,Moreno Mary E.,Rivera Jose M.,Galkina Sofiya A.,Kosikova Galina,Stoddart Cheryl A.,McCune Joseph M.,Myers Lara M.,Weissman Irving L.,Lang Karl S.,Hasenkrug Kim J.^ORCID

Funder

Deutsche Forschungsgemeinschaft

Research Training Group

University of Duisburg-Essen

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Virginia and D.K. Ludwig Fund for Cancer Research

Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation

Virginia and Daniel Ludwig Cancer Foundation

Stanford

Bay Area Lyme Foundation

NIH

NRSA

National Institutes of Health

NIAID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference49 articles.

1. CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin’s lymphoma;Advani;N. Engl. J. Med.,2018

2. CD47-SIRPα interactions regulate macrophage uptake of Plasmodium falciparum-infected erythrocytes and clearance of malaria in vivo;Ayi;Infect. Immun.,2016

3. CD47 regulates the phagocytic clearance and replication of the Plasmodium yoelii malaria parasite;Banerjee;Proc. Natl. Acad. Sci. USA,2015

4. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target;Barclay;Annu. Rev. Immunol.,2014

5. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy;Barkal;Nat. Immunol.,2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD47-mediated immune evasion in early-stage lung cancer progression;Biochemical and Biophysical Research Communications;2024-08

2. Bioconjugated Antibody‐Trojan Immune Converter Enhance Cancer Immunotherapy with Minimized Toxicity by Programmed Two‐Step Immunomodulation of Myeloid Cells;Advanced Healthcare Materials;2024-05-27

3. Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion;Discover Oncology;2024-05-08

4. Airway epithelial CD47 plays a critical role in inducing influenza virus-mediated bacterial super-infection;Nature Communications;2024-04-30

5. YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells;Frontiers in Oncology;2024-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3